Home / Mumbai / Mumbai News / Article / Mumbai's Haffkine Bio-Pharma targets 22.8 crore Covaxin vials a year

Mumbai's Haffkine Bio-Pharma targets 22.8 crore Covaxin vials a year

A top official said the state-run company is targeting to produce 22.8 crore vials of the vaccine per year.

Listen to this article :
A frontline worker gets a Covaxin shot at JJ Hospital in south Mumbai. File pic

A frontline worker gets a Covaxin shot at JJ Hospital in south Mumbai. File pic

After receiving permission to make Bharat Biotech's COVID-19 vaccine Covaxin, Mumbai-based Haffkine Bio-Pharmaceutical on Friday said it would take least at one year's time for the company to start actual production.

How do you like the new new mid-day.com experience? Share your feedback and help us improve.

Read Next Story
Maharashtra to face shortage of Remdesivir for next 2 to 3 days: Minister

Trending Stories

Latest Photoscta-pos

Latest VideosView All

Latest Web StoriesView All

Mid-Day FastView All

Advertisement